Bristol-Myers Squibb Hits All-Time High Off FDA Approval For Expanded Use Of Opvido
March 04, 2015 at 14:33 PM EST
Joel Elconin is the co-host of Benzinga's #PreMarket Prep, a daily trading idea radio show. Bristol-Myers Squibb Co (NYSE: ...